Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,651,509 papers from all fields of science
Search
Sign In
Create Free Account
Drug-Eluting Stents
Known as:
Drug-Eluting Stent
, Stents, Drug-Eluting
, Stents, Drug Eluting
Expand
Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Microbiological
standards characteristics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing.
V. Džavík
,
A. Colombo
JACC: Cardiovascular Interventions
2014
Corpus ID: 7806164
Highly Cited
2013
Highly Cited
2013
Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical…
V. Farooq
,
P. Serruys
,
+15 authors
R. Virmani
JACC: Cardiovascular Interventions
2013
Corpus ID: 205794952
Highly Cited
2012
Highly Cited
2012
Residual platelet reactivity, bleedings, and adherence to treatment in patients having coronary stent implantation treated with prasugrel.
G. Parodi
,
Benedetta Bellandi
,
+6 authors
D. Antoniucci
American Journal of Cardiology
2012
Corpus ID: 2489551
Highly Cited
2008
Highly Cited
2008
Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.
D. Malenka
,
A. Kaplan
,
F. L. Lucas
,
S. Sharp
,
J. Skinner
Journal of the American Medical Association (JAMA…
2008
Corpus ID: 17015626
CONTEXT Although drug-eluting stents reduce restenosis rates relative to bare-metal stents, concerns have been raised that drug…
Expand
Review
2008
Review
2008
Drug-eluting stents—what should be improved?
J. Steffel
,
F. Eberli
,
T. Lüscher
,
F. Tanner
Annals medicus
2008
Corpus ID: 22388699
Despite the success of drug-eluting stents (DES) in reducing restenosis and the need for target vessel revascularization, several…
Expand
Review
2006
Review
2006
Severe, diffuse coronary artery spasm after drug-eluting stent placement.
B. Brott
,
A. Anayiotos
,
G. Chapman
,
P. Anderson
,
W. Hillegass
The Journal of invasive cardiology
2006
Corpus ID: 13527668
OBJECTIVES Three cases of severe, diffuse coronary artery spasm after drug-eluting stent placement at our institution prompted…
Expand
Review
2005
Review
2005
Percutaneous coronary interventions with stents in cardiac transplant recipients.
F. Bader
,
A. Kfoury
,
+5 authors
D. Renlund
The Journal of Heart and Lung Transplantation
2005
Corpus ID: 23490353
Review
2005
Review
2005
The future of drug eluting stents
Rafik R Anis
,
Karl R. Karsch
,
R. Prof.Karl
,
Karsch
Heart
2005
Corpus ID: 28814559
In-stent restenosis (ISR) is the major drawback of percutaneous coronary interventions, occurring in 10–40% of patients. Drug…
Expand
Review
2004
Review
2004
Clinical impact of stent construction and design in percutaneous coronary intervention.
K. Lau
,
K. Mak
,
J. Hung
,
U. Sigwart
American Heart Journal
2004
Corpus ID: 23388160
Review
2003
Review
2003
Drug-eluting stents: potential applications for peripheral arterial occlusive disease.
S. Duda
,
T. Poerner
,
+4 authors
K. Haase
Journal of Vascular and Interventional Radiology
2003
Corpus ID: 30013918
Many different approaches have been evaluated to prevent restenosis in stents after vascular implantation. Currently, drug…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE